BullFrog AI Holdings (BFRGW) Cash & Equivalents Growth (1y) (2022 - 2026)
Powered by 
Analysis
BullFrog AI Holdings (BFRGW) Cash & Equivalents Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.04 Bn | 197.05 Bn | 7.24 Bn | 74.25% |
| 2 | Gilead Sciences | 181.32 Bn | 178.14 Bn | 6.22 Bn | -38.20% |
| 3 | Vertex Pharmaceuticals | 132.20 Bn | 124.35 Bn | 2.84 Bn | 23.56% |
| 4 | Regeneron Pharmaceuticals | 82.41 Bn | 74.42 Bn | 3.93 Bn | 23.05% |
| 5 | Argenx Se | 61.58 Bn | 56.39 Bn | 1.37 Bn | 71.81% |
| 6 | Moderna | 54.71 Bn | 49.57 Bn | 52.00 Mn | 34.71% |
| 7 | Alnylam Pharmaceuticals | 34.15 Bn | 30.84 Bn | 992.69 Mn | 53.39% |
| 8 | Biogen | 31.25 Bn | 29.97 Bn | 1.96 Bn | -53.42% |
| 9 | Roivant Sciences | 30.09 Bn | 30.09 Bn | 1.16 Mn | - |
| 10 | BullFrog AI Holdings | 1.84 Mn | -5.08 Mn | 106,899.00 | 168.29% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 168.29% |
| Dec 31, 2025 | -59.83% |
| Sep 30, 2025 | -50.56% |
| Jun 30, 2025 | -54.07% |
| Mar 31, 2025 | -45.77% |
| Dec 31, 2024 | 107.11% |
| Sep 30, 2024 | 9.93% |
| Jun 30, 2024 | 2.83% |
| Mar 31, 2024 | 29.36% |
| Dec 31, 2023 | 4,451.29% |
| Dec 31, 2022 | 475.89% |